PLx Pharma Inc reports results for the quarter ended in March - Earnings Summary

PLx Pharma Winddown

13/05/2022 14:31

* PLx Pharma Inc  PLXP.OQ  reported a quarterly adjusted
loss
of 39 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 72 cents per share.
    * Revenue was $2.08 million​;  analysts expected $2.53
million. 
    * PLx Pharma Inc's reported EPS for the quarter was a loss
of 39
cents​.
    * The mean earnings estimate of analysts had fallen by
about 31.3%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * PLx Pharma Inc shares had fallen by 49.8% this quarter and
lost 74.7% so far this year.
    * The company reported a quarterly loss of $10.79 million.
    * Wall Street's median 12-month price target for PLx Pharma
Inc is
$16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 01:31 p.m.  ​All
figures in US dollars unless otherwise stated